Similarly, another study of participants with HBV or a history of chronic hepatitis (n = 18,816) in Shanghai found that, despite a low adherence of 58.2%, biannual screening with AFP and ultrasound reduced HCC mortality by 37%41. This evidence concerns the gene AFP and hepatocellular carcinoma.